Discover

SPRY
ARS Pharmaceuticals, Inc.
4.23
2 x 3.89
2 x 6.72
bid
ask
-
0.33
7.24%
2 @ 05:50 PM
4.33 +0.10 (2.36%)
Ytd-63.69%
1y-63.47%
4.20
day range
4.55
4.07
52 week range
13.06
Open4.55Prev Close4.56Low4.20High4.55Mkt Cap420.66M
Vol1.26MAvg Vol1.86MEPS-2.18P/EN/AForward P/E-11.01
Beta0.83Short Ratio13.70Inst. Own95.47%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1050-d Avg5.15200-d Avg7.991yr Est28.80

SPRY News

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
gurufocus.com
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS

[url="]Schall, Brown and Schwartz LLP[/url] (“SBS”), a national shareholder rights litigation fi

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
businesswire.com
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS

LOS ANGELES--(BUSINESS WIRE)---- $SPRY--SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals,

SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
businesswire.com
SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities

NEW YORK--(BUSINESS WIRE)---- $SPRY #ARS--Faruqi & Faruqi, LLP, a leading national securities law fi

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
gurufocus.com
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS

ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
gurufocus.com
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss

ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss

ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
prnewswire.com
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss

NEW YORK, Oct. 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS

LOS ANGELES, Oct. 5, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehold

ARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY
newsfilecorp.com
ARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc.

New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor righ

SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
newsfilecorp.com
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Se

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
benzinga.com
Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Movi

U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting w

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results

ARS Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
benzinga.com
ARS Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

ARS Pharmaceuticals (NASDAQ:SPRY) reported second-quarter financial results on Thursday. The transcr

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session

benzinga.com
ARS Pharmaceuticals Q2 EPS $(0.63) Misses $(0.48) Estimate, Sales $33.658M Beat $31.321M Estimate

ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.63) per share which missed the an

Can ARS Pharma's New CEO Unlock Neffy's Potential?
benzinga.com
Can ARS Pharma's New CEO Unlock Neffy's Potential?

ARS Pharma (SPRY) co-founder Richard Lowenthal steps down as CEO. President Donn Casale succeeds him

benzinga.com
ARS Pharmaceuticals CEO Richard Lowenthal To Depart, Effective July 6; President Donn Casale Named S

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-ris

Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
benzinga.com
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stock

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

ARS Pharma Reaffirms 2027 Breakeven Goal Despite Missing July Neffy Coverage Wins
benzinga.com
ARS Pharma Reaffirms 2027 Breakeven Goal Despite Missing July Neffy Coverage Wins

ARS Pharma reaffirmed its 2027 breakeven target, cut expenses and gained Florida Medicaid access for

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'

Gold Gains Over 1%; Fed's Preferred Inflation Gauge Surges To 3-Year High
benzinga.com
Gold Gains Over 1%; Fed's Preferred Inflation Gauge Surges To 3-Year High

U.S. stocks traded mostly higher, with the Nasdaq Composite down 0.1%. Industrials jumped 2.5%, whil

benzinga.com
Leerink Partners Maintains Outperform on ARS Pharmaceuticals, Lowers Price Target to $24

Leerink Partners analyst Roanna Ruiz maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperfor

H.B. Fuller, Trip.com, Hertz Global And Other Big Stocks Moving Lower In Thursday Pre-Market Session
benzinga.com
H.B. Fuller, Trip.com, Hertz Global And Other Big Stocks Moving Lower In Thursday Pre-Market Session

U.S. stock futures up, Nasdaq 100 futures gain 2%. H.B. Fuller shares dip 8.3% on earnings release a

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m

Why Micron Technology Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Micron Technology Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Shares of Micron Technology Inc (NASDAQ: MU) surged in pre-market trading after reporting strong Q3

ARS Pharmaceuticals (SPRY) Stock Sinks After-Hours After Commercial Update On Neffy Coverage
benzinga.com
ARS Pharmaceuticals (SPRY) Stock Sinks After-Hours After Commercial Update On Neffy Coverage

SPRY stock drops after ARS says no new neffy coverage decisions in July formulary cycle.

9 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
9 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-

benzinga.com
ARS Pharma Lowers 2026 Cash Operating Expense Guidance To $248M And Reaffirms Path To Cash-Flow Brea

No new commercial formulary additions or coverage decisions issued for neffy (epinephrine nasal spra

benzinga.com
ARS Pharmaceuticals Continues To Reduce Cash-Based Operating Expenses After No New Commercial Formul

Access and payer coverage: Despite certain payer discussions ongoing until mid-June, based on recent

benzinga.com
Cantor Fitzgerald Maintains Overweight on ARS Pharmaceuticals, Raises Price Target to $30

Cantor Fitzgerald analyst Josh Schimmer maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Overwe

ARS Pharmaceuticals Q1 2026 Earnings Call Transcript
benzinga.com
ARS Pharmaceuticals Q1 2026 Earnings Call Transcript

Earnings Scheduled For May 15, 2026
benzinga.com
Earnings Scheduled For May 15, 2026

benzinga.com
ARS Pharmaceuticals Q1 EPS $(0.61) Misses $(0.52) Estimate, Sales $22.681M Beat $22.230M Estimate

ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.61) per share which missed the an

ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
benzinga.com
ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's M

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) to release first quarter earnings on May 15 before opening

Dow Settles Above 50,000: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
benzinga.com
Dow Settles Above 50,000: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

The CNN Business Fear & Greed Index, a measure of market sentiment, improved slightly on Thursda

benzinga.com
ARS Pharmaceuticals Appoints Donn Casale President, Effective June 1

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), a biopharmaceutical company dedicated to empowering patient

benzinga.com
Health Canada Approves ARS Pharmaceuticals' Neffy 2 Mg (Epinephrine Nasal Spray) For The Emergency T

"The approval of neffy by Health Canada marks a meaningful advancement for the more than 2.5 mil

benzinga.com
FDA Approves ARS Pharmaceuticals Updating Neffy 1 mg Prescribing Information To Remove Age Criteria

Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of ag

Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday
benzinga.com
Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday

Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer

ARS Pharmaceuticals: Q4 Earnings Insights
benzinga.com
ARS Pharmaceuticals: Q4 Earnings Insights

benzinga.com
ARS Pharmaceuticals Q4 EPS $(0.42) Beats $(0.44) Estimate, Sales $28.087M Beat $25.584M Estimate

ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.42) per share which beat the anal

Earnings Scheduled For March 9, 2026
benzinga.com
Earnings Scheduled For March 9, 2026

Exploring ARS Pharmaceuticals's Earnings Expectations
benzinga.com
Exploring ARS Pharmaceuticals's Earnings Expectations

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

Earnings Scheduled For November 10, 2025
benzinga.com
Earnings Scheduled For November 10, 2025

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
Earnings Scheduled For August 13, 2025

benzinga.com
Earnings Scheduled For May 14, 2025

Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
benzinga.com
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big S

benzinga.com
Earnings Scheduled For March 20, 2025